J&J Report Lifts Guidant Shares
692883
Shares of medical device maker Guidant Corp. jumped on Tuesday after a report saying the company was in advanced talks to be acquired by health products maker Johnson & Johnson  for more than &#36;24 billion.
521877
INDIANAPOLIS - New Jersey-based health care products giant Johnson &amp; Johnson is buying Guidant Corp., one of the world&#39;s top makers of cardiac devices, for about $25.4 billion in cash and stock.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.
378404
Charges hurt the quarterly results of  Johnson & Johnson, Merck & Co. and Schering-Plough Corp., but  the drugmakers' shares rose as J&J's earnings beat Wall Street  forecasts and Merck sales edged higher despite the withdrawal  of its best-selling Vioxx arthritis drug.
397609
U.S. stocks rose on Monday after a report showing manufacturing was still expanding lifted shares of many large industrial companies, including General Electric Co. , and a big drop in oil prices added to buying momentum.
437703
Health care giant Johnson &amp; Johnson is reportedly in advanced negotiations to acquire medical device maker Guidant Corp. for more than $24 billion.
605466
Johnson &amp; Johnson last night struck a deal to acquire Guidant, the US cardiac treatment group for $25.4bn, in a move that will give it access to one of the fastest growing areas in health care.
336391
U.S. blue chips closed slightly higher  on Thursday, helped by Johnson & Johnson Inc.'s JNJ.N $25  billion deal to buy Guidant Corp. GDT.N, but the broader  market fell, with Goldman Sachs Group Inc. GS.N dragging the  S&P 500 lower after posting quarterly revenues that  disappointed Wall Street.
290458
Shares of medical device maker Guidant  Corp. GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
680919
Johnson &amp; Johnson, the maker of Band- Aids and other products, is in talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing unidentified executives familiar with the talks.
769169
Johnson Controls Inc. JCI.N, said on  Tuesday that quarterly earnings rose on growth in both its  automotive interiors and building controls business.
200948
Johnson &amp; Johnson said Wednesday night that it would acquire Indianapolis-based medical device manufacturer Guidant Corp. for $25.4 billion.
555469
Diversified health-care company  Johnson & Johnson JNJ.N on Tuesday said its quarterly profit  rose on higher sales of prescription drugs and medical devices.
25737
Johnson Controls Inc. JCI.N, said on  Tuesday that quarterly earnings rose 24 percent on growth in  both its automotive interiors and building controls business.
462708
Health care and consumer products maker Johnson &amp; Johnson is close to finalizing its long-rumored $24 billion cash and stock acquisition of medical-device maker Guidant Corp.
39192
Win-win? That could be the case for Ronald W. Dollens if Johnson &amp; Johnson (nyse: JNJ - news - people ) has its way. Dollens is president and chief executive of Guidant (nyse: GDT - news - people ), J&amp;J&#39;s takeover target.
97019
Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, an Indianapolis-based medical device maker, for more than $24 billion, executives close to the talks said Monday.